When it comes to managing type 2 diabetes and supporting weight loss, patients often face the choice between Semaglutide ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...

Put simply, Ozempic and Wegovy are both brand names – but they’re both variations of a weight loss drug called semaglutide.

If you’re taking semaglutide for diabetes or weight loss, a new once-a-month injection could soon make it easier to stick to ...

Innovative semaglutide hydrogel may revolutionize diabetes treatment by reducing the need for injections to just once a month ...

Overweight and obese people with heart disease were less likely to die during a trial if taking semaglutide, a recent study found.

Calorie-managed diets and exercise have been the mainstay approach of commercial weight loss programs for decades. But as semaglutide weight loss medications like Ozempic, Wegovy and others become ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

In rodents, semaglutide has been linked to an increased risk of thyroid C-cell tumors. It’s not clear if semaglutide also increases the risk of thyroid cancer in humans. It may be a good idea to avoid ...

An injectable hydrogel provided a sustained release of semaglutide for 1 month in rats, according to preclinical testing of ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...